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Abstract
Background
Anaemia in pregnancy is a major public health and economic problem worldwide, that con-
tributes to both maternal and fetal morbidity and mortality.
Objective
The aim of the study was to calculate the prevalence of anaemia in early pregnancy in a co-
hort of ‘low risk’ women participating in a large international multicentre prospective study
(n = 5 609), to identify the modifiable risk factors for anaemia in pregnancy in this cohort,
and to compare the birth outcomes between pregnancies with and without anaemia in
early gestation.
Methods
The study is an analysis of data that were collected prospectively during the Screening for
Pregnancy Endpoints study. Anaemia was defined according to the World Health Organiza-
tion’s definition of anaemia in pregnancy (haemoglobin< 11g/dL). Binary logistic regression
with adjustment for potential confounders (country, maternal age, having a marital partner,
ethnic origin, years of schooling, and having paid work) was the main method of analysis.
Results
The hallmark findings were the low prevalence of anaemia (2.2%), that having no marital
partner was an independent risk factor for having anaemia (OR 1.34, 95% CI 1.01-1.78),
and that there was no statistically significant effect of anaemia on adverse pregnancy out-
comes (small for gestational age, pre-tem birth, mode of delivery, low birth weight, APGAR
score< 7 at one and five minutes). Adverse pregnancy outcomes were however more com-
mon in those with anaemia than in those without.
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Conclusion
In this low risk healthy pregnant population we found a low anaemia rate. The absence of a
marital partner was a non-modifiable factor, albeit one which may reflect a variety of con-
founding factors, that should be considered for addition to anaemia’s conceptual framework
of determinants. Although not statistically significant, clinically, a trend towards a higher risk
of adverse pregnancy outcomes was observed in women that were anaemic in
early pregnancy.
Introduction
Anaemia is a state where the delivery of oxygen to the tissues is impaired because of a quantita-
tive or qualitative deficiency of haemoglobin or red blood cells [1]. According to the World
Health Organization (WHO), anaemia in pregnancy occurs when, at sea level, the haemoglobin
is< 11 g/dL or the haematocrit is< 33%, regardless of gestation [2,3].
The United States Centers for Disease Control and Prevention’s (CDC) definition of anae-
mia in pregnancy differs from the WHO definition only in the second trimester where the cut
off haemoglobin is< 10.5 g/dL and haematocrit is< 32% [4].
Despite these definitions, anaemia in pregnancy is not quite straight forward, because of the
physiologic changes that occur during pregnancy, which also involve the haematologic system
[5]. Some authorities maintain that additional variables of altitude, cigarette smoking and eth-
nicity may alter the definition of anaemia in individuals [6,7]. Others are of the opinion that al-
titude should not modify the definition [8] and that there is insufficient information to alter
the definition of anaemia based on ethnicity [3].
These subtleties of defining anaemia in pregnancy are important as they have implications
for comparisons between studies and between populations. Stephens et al. reported that ap-
proximately 38% of pregnant women worldwide are anaemic [9]. The estimated prevalence of
anaemia in pregnancy differs widely between continents, being highest in Africa (55.8%) and
Asia (41.6%), and lowest in Europe (18.7%) and North America (6.1%) [10]. In general, as
pregnancy progresses, the prevalence of anaemia increases [11].
Anaemia in pregnancy is a major public health and economic problem worldwide and con-
tributes to both maternal and fetal morbidity and mortality; anaemia of pregnancy can also
have profound short-term and far-reaching sequelae for the newborn [12–14]. Anaemia, even
in early pregnancy has been associated with adverse pregnancy outcome [15]. Clinical manifes-
tations include fetal growth restriction, preterm delivery, low birth weight [16], impaired lacta-
tion, poor maternal/infant behavioural interactions, post partum depression and increased
fetal and neonatal mortality [12,13]. Economic losses occur because iron deficiency anaemia
has been associated with decreased work capability of adults and reduced cognitive function of
children that may persist into adulthood; impaired motor development a manifestation of
anaemia also adds to economic loss [9,17].
The risk factors/determinants/causes of anaemia can be found at multiple interacting levels
[18].The immediate causes of anaemia can be considered to be decreased red blood cell/haemo-
globin production and increased loss of red blood cells/haemoglobin, as a result of nutritional,
infectious and genetic influences. Some of the important risk factors include deficiency of nu-
trients such as iron (apparently the most common risk factor), folate and vitamin B12, infec-
tions such as human immunodeficiency virus (HIV), malaria and hook worms, and disorders
in the structure or production of haemoglobin such as sickle cell disease and the thalassemias
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[12,13]. The aetiology of anaemia in pregnancy can be considered in the broader context of
Balarajan and colleagues’ “Conceptual model of the determinants of anaemia” (see Fig 1),
whereby alterations in the political economy, climate, ecology, cultural norms, etc. eventually
culminate in decreased red blood cell/haemoglobin production and increased loss. Other risk
factors in the conceptual model include teenage pregnancy, ‘low’ educational level, ‘poor’ socio-
economic status, a short inter pregnancy interval and high parity [18–20]. In aggregate, nutri-
tional, infectious and genetic risk factors for anaemia are less common in high income than in
low and middle income countries [21].
Impaired delivery of oxygen to tissues appears to be the central mechanism by which anae-
mia increases the risk of maternal organ (brain, heart, kidney) injury and mortality [22]. Oxy-
gen delivery to the uterus (and fetus) may be reduced in pregnant women with anaemia
because of this impaired tissue oxygen delivery [23].
The primary aims of this study were to determine the modifiable risk factors for anaemia in
early pregnancy, and to compare the pregnancy outcomes between women with and without
anaemia in early pregnancy.
Materials and Methods
The SCOPE (SCreening fOr Pregnancy Endpoints) study is an international, prospective, mul-
ticentre cohort study of 5 690 ‘low-risk’ nulliparous women with singleton pregnancies in four
high income countries: New Zealand, Australia, England and Ireland (www.scopestudy.net/).
The primary aim of the SCOPE study is to develop screening tests to predict pre-eclampsia,
fetal growth restriction and spontaneous preterm births in a low risk population.
Details of the SCOPE study methods have been published in detail elsewhere [24] but in
brief, recruitment of participants into the study started in Auckland, New Zealand in Novem-
ber 2004 and finished in Cork, Ireland in February 2011. The participants ranged in age from
16 to 45 years and were recruited into the study before 15 weeks’ gestation, through community
midwives, general practitioners, hospital antenatal clinics, obstetricians and self referral. Wom-
en’s partners, along with their newborn infants, are also involved in the study. Women were ex-
cluded if they: 1) were considered to be at high risk of pre-eclampsia, fetal growth restriction or
spontaneous preterm birth due to underlying medical conditions (chronic hypertension, diabe-
tes, renal disease, systemic lupus erythematosus, anti-phospholipid syndrome, sickle cell dis-
ease, HIV), previous cervical knife cone biopsy, 3 previous terminations or 3 miscarriages,
current ruptured membranes; 2) had a major uterine anomaly, a known major fetal anomaly
or abnormal karyotype; or 3) received an intervention that could modify pregnancy outcome
(e.g. aspirin therapy, cervical suture).
At 14–16 weeks’ and 19–21 weeks’ gestation, participants were interviewed and examined
by a research midwife, and underwent blood and urine tests. An ultrasound scan was per-
formed at 19–21 weeks. Participants were followed prospectively, with pregnancy outcome
data and baby measurements collected by research midwives.
Ethical approval was obtained from local ethics committees [New Zealand AKX/02/00/364,
Australia REC 1712/5/2008, London and Manchester 06/MRE01/98 and Cork ECM5(10)05/
02/08] and all women provided written informed consent. For the secondary analysis of the
SCOPE study dataset, presented in this paper, ethics approval was sought from the Human Re-
search Ethics Committee (Medical) of the University of the Witwatersrand M130966.
Prior to analysis, each participant’s measured booking haemoglobin (obtained typically in
the first trimester) was adjusted to take into account cigarette smoking during three months
pre-pregnancy up to and including the first study visit at 14–16 weeks (data on smoking was
available for this time period). The adjustment was made according to the WHO criteria [3,6]
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Fig 1. Conceptual model of the determinants of anaemia, reproduced with permission from Balarajan et al. [18].
doi:10.1371/journal.pone.0122729.g001
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(see Table 1). Because smoking has effects which can persist via epigenetic changes [25], and
haematological indices can take years to return to normal after smoking cessation [26], an ad-
justment to the measured haemoglobin was made considering the entire period for which data
on smoking was available. The adjusted haemoglobin was then used to classify participants as
having anaemia or not according to the WHO definition of anaemia in pregnancy. No adjust-
ment to the haemoglobin for altitude was made because all the participating SCOPE centres
were below 1 000m above sea level.
We investigated the following risk factors for their association with anaemia: maternal age,
country, marital status, ethnicity, schooling, paid work, body mass index, maternal socioeco-
nomic index, fruit consumption, vegetable consumption, folate intake, iron and mineral intake,
alcohol, psychological scales, paternal age and socioeconomic index. We investigated the fol-
lowing outcomes for their association with anaemia: small for gestational age, preterm delivery,
mode of delivery, low birth weight and APGAR score. The variables were examined as pre-
sented in Table 2.
Statistical analysis
All statistical analysis was conducted using Stata version 13IC (StataCorp LP College Station,
TX). Continuous variables were tested for normality using histograms and inverse normal
plots. The continuous variables were described using the mean (standard deviation—SD) if
normally distributed or median (interquartile range—IQR) if not normally distributed.
Frequency (n) and percent (%) were used to report categorical variables. To compare cate-
gorical variables, Pearson’s Chi-squared or Fisher’s exact test was used, where appropriate. For
the comparison of normally distributed continuous variables, Student’s t-test (two-sample t-
test) was used; for non-normally distributed data, the Mann-Whitney test was used.
Kaplan-Meier (KM) curves were plotted, depicting anaemic and non-anaemic participants
with regard to their time to delivery. The logrank test was used to ascertain the equality of sur-
vivor functions with p-value< 0.05 being considered statistically significant. Although the me-
dian gestational ages could have been compared in each anaemia group, KM (survival) plots
give a visual depiction and they are less of a summary than the medians.
Two-tailed p-values were reported. Because of multiple testing (30 tests were planned), in
order to reduce the chances of a false positive result (type 1 error), Bonferonni’s method (0.05
 30) was used, giving an adjusted significance threshold of p<0.002.
It has been suggested that methods using forward stepwise selection (or backward selection
or a combination of both forward and backward selection) based on pre-determined p-value
criteria are not optimal [27]. A better approach to determine which variables to include or
Table 1. Criteria for the adjustment of haemoglobin due to smoking cigarettes.
Smoking status* Measured haemoglobin adjustment (g/dL)
Non-smoker 0
< 10 cigarettes 0
10-<20 cigarettes -0.3
 20-<40 -0.5
40 cigarettes -0.7
* Number of cigarettes smoked per day: < 10 cigarettes, < ½ packet; 10-<20 cigarettes, ½-1 packet; 
20-<40 cigarettes, 1–2 packets; 40 cigarettes, 2 packets
doi:10.1371/journal.pone.0122729.t001
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Table 2. Comparison of participants without and with anaemia.
Characteristic Not anaemic Anaemica p-valueb
n = 5 484 n = 125
n (%) n (%)
Maternal
Age (years), median IQRc 29 (25–32) 28 (22–33) 0.2359
Teenager 391 (7.1) 14 (11.2) 0.082
Country 0.008
Australia 1 130 (20.6) 30 (24.0)
Ireland 1 742 (31.8) 28 (22.4)
New Zealand 1 980 (36.1) 42 (33.6)
United Kingdom 632 (11.5) 25 (20.0)
Haemoglobin (g/dL), median IQRc 12.8 (12.3–13.4) 10.7 (10.4–10.8) < 0.001*
No marital partner 518 (9.5) 20 (16.0) 0.014
Ethnic origin < 0.001*
European 4 947(90.2) 97 (77.6)
Asian 160 (2.9) 9 (7.2)
Indian 125 (2.3) 9 (7.2)
Polynesian 113 (2.1) 2 (1.6)
Other (including African) 139 (2.5) 8 (6.4)
Schooling  12 years 2 054 (37.4) 63 (50.4) 0.003
No paid work at 15 weeks visit 795 (14.5) 29 (23.2) 0.007
Body mass index (kg/m2)(ethnicity adjusted,evaluated at 14–16 weeks) 0.583
< 18.5 82 (1.5) 2 (1.6)
 18.5– < 25 2 998 (54.7) 76 (60.8)
 25.0 –< 30 1 564 (28.5) 31 (24.8)
 30 840 (15.3) 16 (12.8)
Socioeconomic index, median IQRc 45 (28–50) 43 (27–50) 0.3058
High fruit intake a month before conception (consumption  3 times per day) 1 234 (22.5) 23 (18.4) 0.277
High green leafy vegetable intake a month before conception (consumption  3 times per day) 329 (6.0) 7 (5.6) 0.852
Folate (supplementation in pill form)
no intake before pregnancy 2 267 (41.3) 72 (57.6) < 0.001*
no intake during ﬁrst trimester 2 19 (4.0) 7 (5.6) 0.366
Iron or mineral (supplementation in pill form)
no intake before conception 3 502 (96.5) 70 (92.1) 0.043
data missing 1 854 (33.8) 49 (39.2)
no intake during ﬁrst trimester 3 454 (95.0) 64 (84.2) < 0.001*
data missing 1 849 (33.7) 49 (39.2)
Alcohol (units), > 14 units per week (1 unit = 8g pure alcohol)
3 months pre-pregnancy 602 (11.0) 15 (12.0) 0.718
First trimester 342 (6.2) 6 (4.8) 0.510
Psychological scales(evaluated at 14–16 weeks)
Edinburgh Postnatal Depression Score 10 1 435 (26.3) 41 (33.6) 0.069
data missing 21 (0.4) 3 (2.4)
Short form State-Trait Anxiety Inventory Score > 90th centile 433 (7.9) 14 (11.5) 0.154
data missing 27 (0.5) 3 (2.4)
Perceived Stress Scale Score > 90th centile 483 (8.9) 18 (14.8) 0.024
data missing 30 (0.5) 3 (2.4)
Paternal
Age (years), median IQRc 31 (27–35) 30 (25–34) 0.0575
(Continued)
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exclude in the multivariable logistic regression model is by using external clinical judgment,
which is the approach that was adopted in this analysis [27]. The models were adjusted for
country, maternal age, having a marital partner, ethnic origin, years of schooling, and having
paid work, the a priori variables. Participant data may not have been independent of the
SCOPE centres. To take account of this, the cluster option in Stata was used.
A sensitivity analysis was conducted where all the participants with a missing booking hae-
moglobin were assumed to be anaemic.
Results
Fig 2 depicts the inclusion of participants in the final analysis; 5 690 participants were recruited
into the SCOPE study at 14–16 weeks (STROBE Statement: S1 Table). Forty-eight participants
(0.8%) were lost to follow-up and 14 (0.2%) were ineligible after recruitment. Nineteen (0.3%)
of the 5 628 remaining participants did not have a booking haemoglobin and were excluded,
Table 2. (Continued)
Characteristic Not anaemic Anaemica p-valueb
n = 5 484 n = 125
n (%) n (%)
data missing 1 215 (22.2) 33 (26.4)
Socioeconomic index, median IQRc 44 (29–50) 44 (29–50.5) 0.8451
data missing 1 215 (22.2) 33 (26.4)
Pregnancy outcome
Small for gestational age (<10th percentile for customized birthweight centiles) 617 (11.3) 13 (10.5) 0.778
data missing 20 (0.4) 1 (0.8)
Preterm delivery (< 37 completed weeks)
All 347 (6.3) 9 (7.2) 0.698
data missing 14 (0.3) 0 (0)
Spontaneous 227 (4.2) 7 (5.6) 0.423
data missing 14 (0.3) 0 (0)
Mode of delivery 0.307
Unassisted vaginal 2 477 (45.3) 47 (37.9)
Operative vaginal 1 444 (26.4) 35 (28.2)
Pre-labour Caesarean section 486 (8.9) 11 (8.9)
Caesarean section in labour 1 058 (19.4) 31 (25.0)
data missing 19 (0.3) 1 (0)
Low birth weight (< 2500g) 282 (5.2) 9 (7.3) 0.300
data missing 27 (0.5) 1 (0.8)
APGAR score at 1 minute < 7 496 (9.2) 16 (12.9) 0.159
data missing 87 (1.6) 1(0.8)
APGAR score at 5 minutes < 7 60 (1.1) 1 (0.8) 0.754
data missing 88 (1.6) 2 (1.6)
a The presence or absence of anaemia was adjusted for smoking
b Pearson’s χ2 test or Fisher's exact test
c Mann-Whitney test
* p-value < 0.002 was considered statistically signiﬁcant
doi:10.1371/journal.pone.0122729.t002
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resulting in a final study population of 5 609 participants at 14–16 weeks. Without adjustment
to the measured haemoglobin, 103 (1.8%) of the participants were anaemic; 125 (2.2%) were
found to be anaemic after adjusting for cigarette smoking.
Table 2 shows the differences between participants with and without anaemia. The median
haemoglobin for those without anaemia was 12.8 g/dL (IQR 12.3–13.4); for those with anaemia
it was 10.7 g/dL (IQR 10.4–10.8). Factors that were significantly associated with having anae-
mia were ethnic origin, reporting folate intake before pregnancy and no iron or mineral intake
in the first trimester.
In the final model, which was of good fit, the variables that were independently associated
with anaemia in early pregnancy were country, ethnic origin and having a marital partner
(Table 3). Assuming that the 19 participants without a booking haemoglobin were anaemic
lead to having paid work and reporting folate intake prior to pregnancy being protective of
anaemia in early pregnancy.
Birth outcomes were similar for anaemic and non-anaemic women (Table 4). The pregnan-
cy outcome findings suggested a trend towards a higher risk of adverse pregnancy outcomes
for some, but not all outcomes.
Although 76.0% of participants did not have data on serum ferritin, 12 (0.88%) participants
with data on serum ferritin were found to have iron deficiency anaemia (defined as serum
ferritin< 12μg/L and haemoglobin< 11g/dL [15]). The median gestational age at delivery was
Fig 2. Participant flow chart, adapted fromMcCarthy et al. [28].
doi:10.1371/journal.pone.0122729.g002
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similar for the anaemic and non-anaemic women: 38.9 and 40.0 weeks, respectively (see Fig 3),
logrank test: p> 0.05. Participants with moderate anaemia had a mean and median gestational
age at delivery of 39.8 and 40.1 weeks respectively while the corresponding values for mildly
anaemic participants were 39.3 and 39.9 weeks. There was no correlation between the adjusted
haemoglobin and birth weight, correlation coefficient 0.0017, p-value = 0.8972.
Discussion
In this contemporary, large multicenter cohort of nulliparous women in their first ongoing
pregnancy we found a very low prevalence of anaemia. The 2.2% prevalence of anaemia in the
SCOPE cohort differs sharply with the 22% prevalence reported from high-income regions in
recent literature [9]. One possible explanation for this is that SCOPE participants were selected
to be ‘low risk’ and were all nulliparous. It is well recognised that co-morbidities such as high
parity and short birth interval can affect anaemic status [18]. Furthermore, despite the multi-
center nature of the cohort, the ethnicity of SCOPE participants was homogeneous with 89.9%
Table 3. Factors associated with anaemia in early pregnancy.
Characteristic Unadjusted OR (95% CI) p-value Adjusted OR (95% CI) p-value
Country
Australia Reference Reference
Ireland 0.61 (0.61–0.61) < 0.001 0.83-(0.68–1.01) 0.060
New Zealand 0.80 (0.80–0.80) < 0.001 0. 93 (0.78–1.10) 0.410
United Kingdom 1.49 (1.08–2.06) 0.016 1.34 (1.06–1.69) 0.016*
Has marital partner Reference Reference
No marital partner 1.83 (1.28–2.61) 0.001 1.34 (1.01–1.78) 0.044*
Ethnic origin
European Reference Reference
Asian 2.87 (1.63–5.031) < 0.001 2.25 (1.19–4.25) 0.012*
Indian 3.67 (2.54–5.32) < 0.001 3.36 (2.42–4.67) < 0.001*
Polynesian 0.90 (0.61–1.35) 0.615 0.71 (0.61–0.84) < 0.001*
Other (including African) 2.94 (1.72–5.02) < 0.001 1.75 (1.30–2.35) < 0.001*
Schooling > 12 years Reference Reference
Schooling  12 years 1.70 (1.39–2.08) < 0.001 1.26 (0.92–1.72) 0.156
No paid work Reference Reference
Paid work 0.56 (0.43–0.73) < 0.001 0.73 (0.49–1.07) 0.108
No folate intake before pregnancy Reference Reference
Folate intake before pregnancy 0.52 (0.34–0.80) 0.003 0.64 (0.40–1.03) 0.066
Edinburgh postnatal depression score
< 10 Reference Reference
 10 1.42 (1.09–1.85) 0.009 1.06 (0.82–1.36) 0.654
Perceived stress scale
 90th centile Reference Reference
> 90th centile 1.78 (0.99–3.21) 0.054 1.47 (0.73–2.96) 0.282
Maternal age (years) 0.97 (0.94–1.00) 0.038 1.02 (0.99–1.05) 0.180
N = 5 575 for adjusted model (The model was adjusted for country, maternal age, having a marital partner, ethnic origin, years of schooling, and having
paid work)
OR (Odds Ratio), CI (Conﬁdence Interval)
* p-values < 0.05 were considered statistically signiﬁcant
doi:10.1371/journal.pone.0122729.t003
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of European ancestry. We did not adjust our findings for ethnic specific variations in haemo-
globin concentration because of the low numbers of non-Caucasian participants and because
there is sparse data on how to adjust the haemoglobin for ethnicity [7], this may also partially
explain our findings. Mandatory folic acid supplementation does not explain the lower inci-
dence of anaemia in this cohort because at the time of patient recruitment none of the partici-
pating countries had mandatory folic acid supplementation programs [29].
In the SCOPE cohort, not having a marital partner was associated with higher odds of hav-
ing anaemia in early pregnancy. This is not surprising because there is evidence that involve-
ment of fathers during pregnancy is associated with diminished negative maternal behaviours
and better neonatal outcomes [30]. In addition, not having a partner suggests that the pregnan-
cy was unintended and therefore women did not take steps to optimize their health prior to
pregnancy. In general, marriage protects pregnancy [31].
In the adjusted analysis, United Kingdom participants had a higher odds ratio of anaemia in
early pregnancy compared to the other countries. It is difficult to untangle the disparate poten-
tial contributions of political economy, ecology, geography and climate, all of which are found
within the conceptual framework of anaemia’s determinants.
Previous studies mainly from low and middle income countries have shown an association
between low education [18,20], the Edinburgh postnatal depression score (the depression
being linked to folic acid deficiency [32,33]) and teenage pregnancy [19], but we did not find
this in our study.
Table 4. Pregnancy outcomes and anaemia status.
Characteristic Unadjusted OR (95% CI) p-value Adjusted OR (95% CI)* p-value
Small for gestational age
Anaemic 0.92 (0.53–1.61) 0.752 0.85 (0.50–1.46) 0.560
Pre-term birth (All)
Anaemic 1.10 (0.61–2.00) 0.752 1.05 (0.57–1.94) 0.864
Pre-term birth (Spontaneous)
Anaemic 1.37 (0.53–3.57) 0.519 1.30 (0.48–3.50) 0.610
Mode of delivery (unassisted vaginal—base outcome)#
Operative vaginal
Anaemic 1.28 (0.69–2.36) 0.434 1.47 (0.75–2.87) 0.259
Pre-labour Caesarean section
Anaemic 1.19 (0.68–2.09) 0.536 1.40 (0.74–2.62) 0.299
Caesarean section in labour
Anaemic 1.54 (0.81–2.95) 0.189 1.73 (0.86–3.46) 0.123
Low birth weight
Anaemic 1.44 (0.67–3.07) 0.351 1.31 (0.62–2.76) 0.485
APGAR score at 1 minute < 7
Anaemic 0.68 (0.39–1.19) 0.178 0.71 (0.41–1.24) 0.232
APGAR score at 5 minutes < 7
Anaemic 1.37 (0.19–10.02) 0.755 1.47 (0.21–10.3) 0.699
(The models were adjusted for country, maternal age, having a marital partner, ethnic origin, years of schooling, and having paid work)
OR (Odds Ratio), CI (Conﬁdence Interval)
Reference group—not anaemic
# Relative risk ratio, multinomial logistic regression
* p-values < 0.05 were considered statistically signiﬁcant
doi:10.1371/journal.pone.0122729.t004
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In our study, from a statistical significance viewpoint, anaemia was not associated with ad-
verse pregnancy outcomes. However, adverse pregnancy outcomes tended to be more common
in those with anaemia than in those without. Low birth weight and preterm delivery were simi-
lar between pregnant women with and without anaemia in early pregnancy. This is at odds
with findings from a recent comprehensive systematic review and meta-analysis [15]. The low
prevalence of anaemia in this study (with small numbers of relevant pregnancy outcomes for
anaemic participants), due to the deliberate recruitment of ‘low risk’ women, could possibly ex-
plain the absence of an effect of anaemia on these adverse pregnancy outcomes.
Contrary to the finding that anaemia prevalence is consistently higher in those of lower so-
cioeconomic status and in those with low body weight [34], in this study the prevalence of
anaemia was similar across paternal and maternal socioeconomic groupings and body weight.
Although confirmation of iron deficiency in pregnancy is difficult [13], iron deficiency
anaemia is reportedly the most common cause of anaemia in pregnancy. Relatively easy access
to iron in fortified cereals and other food products (important sources of iron in industrialized
countries) [35], irrespective of socioeconomic status, may partly explain this lack
of association.
Fig 3. Kaplan-Meier plot estimates of anaemia status and gestational age at delivery. (Note the ‘curious’ behaviour of women with moderate anaemia
who have no pre-term birth and are on average—median and mean—delivering later than women with mild anaemia and even those with no anaemia—
median.).
doi:10.1371/journal.pone.0122729.g003
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Although there were few participants with moderate anaemia, they paradoxically delivered
later, on average, than participants with mild anaemia (of lesser severity). In fact, none of the
participants with moderate anaemia had pre-term labour. This finding contrasts with the
u-shaped relationship described in literature (where pre-term birth is more common at both
very high and very low maternal haemoglobin concentrations and is uncommon at normal
haemogloin levels) [8]. Our finding could be spurious given the small number of participants;
however the finding is biologically plausible because paradoxical results have been found in
transfusion studies where individuals with more severe anaemia do better [36,37]. We are by
no means suggesting that women be made to have moderate anaemia as moderate anaemia
seems to be associated with a longer pregnancy compared to mild anaemia, but the finding is
worth noting because it can generate hypothesis about underlying biological mechanisms and
reveal potential therapeutic targets.
The strengths of this study include its large multi-country prospective cohort design with
excellent follow-up where outcome data were available for approximately 99% of the partici-
pants. Inclusion of parental infant trios and the availability of a large number of clinical vari-
ables further strengthened the study. Stringent real time data monitoring helped to ensure the
quality of the data.
The primary study was designed to develop predictive biomarkers for three late pregnancy
conditions, and not specifically to answer the question posed in the study reported in
this paper.
‘Healthy’ nulliparous women with singleton pregnancies recruited into the SCOPE study
are not representative of the general pregnant population. The primary study was conducted in
high income countries, thus risk factors for anaemia in pregnancy such as malaria and hook
worm infection (which are more common in low and middle income countries) are unlikely to
be identified as significant causes of anaemia. In addition, women with HIV and sickle cell dis-
ease, which are known risk factors for anaemia, were excluded from the primary study.
Cigarette smoking was evaluated by self report as is usual in clinical practice, however un-
derreporting of smoking is possible as cotinine levels—a sensitive marker of smoking tobacco
—were not measured. Nevertheless, in pregnancy, self-reported tobacco use has been found to
be a valid marker of tobacco exposure [38].
Conclusion
In this low risk healthy pregnant population we found a low anaemia rate. The absence of a
marital partner was a non-modifiable factor, albeit one which may reflect a variety of con-
founding factors, that should be considered for addition to the conceptual framework of anae-
mia’s determinants. Although not statistically significant, clinically, a trend towards a higher
risk of adverse pregnancy outcomes was observed in women that were anaemic in
early pregnancy.
Supporting Information
S1 Table. STROBE Statement—Checklist of items that should be included in reports of co-
hort studies.
(DOC)
Acknowledgments
This study was initially carried out as a research report by Gwinyai Masukume in partial fulfill-
ment of the requirements of the MSc in the field of Epidemiology and Biostatistics at the
Risk Factors and Birth Outcomes of Anaemia in Pregnancy - SCOPE Study
PLOS ONE | DOI:10.1371/journal.pone.0122729 April 15, 2015 12 / 15
University of the Witwatersrand School of Public Health. We are grateful to the participants
who volunteered for the SCOPE study, to make pregnancy and child birth even safer. We
thank the SCOPE Country Project Managers R. Taylor, University of Auckland, D. Healy, Uni-
versity of Adelaide, A. Briley, King’s College London, and N. Murphy and E. Snapes, University
College Cork, and the database and statistical support provided by E. H. Y. Chan, University of
Auckland. We acknowledge and thank the SCOPE Principal Investigators, Professors Robyn
North, London, Lesley McCowan, Auckland, Gustaaf Dekker, Adelaide, Lucilla Poston, Lon-
don and James Walker, Leeds.
Author Contributions
Conceived and designed the experiments: GM ASK LCK PNB GN. Performed the experiments:
GM. Analyzed the data: GM ASK. Contributed reagents/materials/analysis tools: GM ASK
LCK PNB GN. Wrote the paper: GM ASK LCK PNB GN.
References
1. Grewal A. Anaemia and pregnancy: Anaesthetic implications. Indian J Anaesth. 2010; 54: 380–386.
doi: 10.4103/0019-5049.71026 PMID: 21189874
2. World Health Organization. Iron Deficiency anaemia. Assessment, Prevention, and Control. A guide for
programmemanagers. 2001. Available: http://www.who.int/nutrition/publications/en/ida_assessment_
prevention_control.pdf.
3. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment
of severity. Vitamin and Mineral Nutrition Information System. 2011. Available: http://www.who.int/
vmnis/indicators/haemoglobin.pdf.
4. Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency
in the United States. MMWRRecommRep. 1998; 47: 1–29. Available: http://www.cdc.gov/mmwr/PDF/
rr/rr4703.pdf. PMID: 9809743
5. Ouzounian JG, ElkayamU. Physiologic changes during normal pregnancy and delivery. Cardiol Clin.
2012; 30: 317–329.doi: 10.1016/j.ccl.2012.05.004 PMID: 22813360
6. Sullivan KM, Mei Z, Grummer-Strawn L, Parvanta I. Haemoglobin adjustments to define anaemia. Trop
Med Int Health. 2008; 10: 1267–1271.doi: 10.1111/j.1365-3156.2008.02143.x PMID: 18721184
7. Harm SK, Yazer MH, Waters JH. Changes in hematologic indices in caucasian and non-caucasian
pregnant women in the United States. Korean J Hematol. 2012; 47: 136–141.doi: 10.5045/kjh.2012.47.
2.136 PMID: 22783361
8. Gonzales GF, Steenland K, Tapia V. Maternal haemoglobin level and fetal outcome at low and high alti-
tudes. Am J Physiol Regul Integr Comp Physiol. 2009; 297: R1477–1485.doi: 10.1152/ajpregu.00275.
2009 PMID: 19741055
9. Stephens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, et al. Global, regional,
and national trends in haemoglobin concentration and prevalence of total and severe anaemia in chil-
dren and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-
representative data. Lancet Glob Health. 2013; 1: e16–25.doi: 10.1016/S2214-109X(13)70001-9
PMID: 25103581
10. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vita-
min and Mineral Nutrition Information System, 1993–2005. Public Health Nutr. 2009; 12: 444–454.
Available: http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf. doi: 10.1017/
S1368980008002401 PMID: 18498676
11. Gonzales GF, Tapia V, Fort AL. Maternal and perinatal outcomes in second haemoglobin measure-
ment in nonanemic women at first booking: effect of altitude of residence in peru. ISRNObstet Gynecol.
2012; 2012: 368571.doi: 10.5402/2012/368571 PMID: 22577573
12. Lee AI, OkamMM. Anaemia in pregnancy. Hematol Oncol Clin North Am. 2011; 25: 241–259.doi: 10.
1016/j.hoc.2011.02.001 PMID: 21444028
13. Goonewardene M, Shehata M, Hamad A. Anaemia in pregnancy. Best Pract Res Clin Obstet Gynaecol.
2012; 26: 3–24.doi: 10.1016/j.bpobgyn.2011.10.010 PMID: 22138002
14. Chang S, Zeng L, Brouwer ID, Kok FJ, Yan H. Effect of iron deficiency anemia in pregnancy on child
mental development in rural China. Pediatrics. 2013; 131: e755–763.doi: 10.1542/peds.2011-3513
PMID: 23400604
Risk Factors and Birth Outcomes of Anaemia in Pregnancy - SCOPE Study
PLOS ONE | DOI:10.1371/journal.pone.0122729 April 15, 2015 13 / 15
15. Haider BA, Olofin I, Wang M, Spiegelman D, Ezzati M, Fawzi WW. Anaemia, prenatal iron use, and risk
of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2013; 346: f3443.doi: 10.
1136/bmj.f3443 PMID: 23794316
16. Levy A, Fraser D, Katz M, Mazor M, Sheiner E. Maternal anaemia during pregnancy is an independent
risk factor for low birthweight and preterm delivery. Eur J Obstet Gynecol Reprod Biol. 2005; 122:
182–186.doi: 10.1016/j.ejogrb.2005.02.015 PMID: 16219519
17. Horton S, Ross J. The economics of iron deficiency. Food Policy. 2003; 28: 51–75.doi: 10.1016/S0306-
9192(02)00070-2
18. Balarajan Y, Ramakrishnan U, Ozaltin E, Shankar AH, Subramanian SV. Anaemia in low-income and
middle-income countries. Lancet. 2011; 378: 2123–2135.doi: 10.1016/S0140-6736(10)62304-5 PMID:
21813172
19. Sagili H, Pramya N, Prabhu K, Mascarenhas M, Reddi Rani P. Are teenage pregnancies at high risk? A
comparison study in a developing country. Arch Gynecol Obstet. 2012; 285: 573–577. doi: 10.1007/
s00404-011-1987-6 PMID: 21789518
20. Noranha JA, Al Khasawneh E, Seshan V, Ramasubramaniam S, Raman S. Anaemia in Pregnancy-
Consequences and Challenges: A Review of Literature. J South Asian Feder Obst Gynae. 2012; 4:
64–70.doi: 10.5005/jp-journals-10006-1177
21. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality
from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Bur-
den of Disease Study. Lancet. 2012; 380: 2095–2128.doi: 10.1016/S0140-6736(12)61728-0 PMID:
23245604
22. Hare GM, Freedman J, David Mazer C. Review article: risks of anaemia and related management strat-
egies: can perioperative blood management improve patient safety? Can J Anaesth. 2013; 60:
168–175.doi: 10.1007/s12630-012-9861-y PMID: 23354944
23. Webster WS, Abela D. The effect of hypoxia in development. Birth Defects Res C Embryo Today.
2007; 81: 215–228.doi: 10.1002/bdrc.20102 PMID: 17963271
24. McCowan L, North R, Taylor R. ACTRN12607000551493. Australian New Zealand Clinical Trials Reg-
istry. 2007. Available: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=82254.
25. Besingi W, Johansson A. Smoke-related DNAmethylation changes in the etiology of human disease.
HumMol Genet. 2014; 23: 2290–2297.doi: 10.1093/hmg/ddt621 PMID: 24334605
26. Van Tiel E, Peeters PH, Smit HA, Nagelkerke NJ, Van Loon AJ, Grobbee DE, et al. Quitting smoking
may restore hematological characteristics within five years. Ann Epidemiol. 2002; 12: 378–388.doi: 10.
1016/S1047-2797(01)00282-4 PMID: 12160596
27. Annals of Internal Medicine. Information for Authors—Statistical Guidelines. 2014. Available: http://
annals.org/SS/AuthorInformationStatisticsOnly.aspx%20#multivariable-analysis.
28. McCarthy FP, Khashan AS, North RA, RahmaMB,Walker JJ, Baker PN, et al. Pregnancy loss man-
aged by cervical dilatation and curettage increases the risk of spontaneous preterm birth. Hum Reprod.
2013; 28: 3197–3206.doi: 10.1093/humrep/det332 PMID: 24052504
29. New Zealand Ministry of Health—Manatū Hauora. Folate/folic acid. Questions and Answers. 2014.
Available: http://www.health.govt.nz/our-work/preventative-health-wellness/nutrition/folate-folic-acid
30. Alio AP, Lewis CA, Scarborough K, Harris K, Fiscella K. A community perspective on the role of fathers
during pregnancy: a qualitative study. BMC Pregnancy Childbirth. 2013; 13: 60.doi: 10.1186/1471-
2393-13-60 PMID: 23497131
31. Raatikainen K, Heiskanen N, Heinonen S. Marriage still protects pregnancy. BJOG. 2005; 112:
1411–1416.doi: 10.1111/j.1471-0528.2005.00667.x PMID: 16167946
32. Goshtasebi A, Alizadeh M, Gandevani SB. Association between maternal anaemia and postpartum de-
pression in an urban sample of pregnant women in Iran. J Health Popul Nutr. 2013; 31: 398–402.
PMID: 24288954
33. Lazarou C, KapsouM. The role of folic acid in prevention and treatment of depression: an overview of
existing evidence and implications for practice. Complement Ther Clin Pract. 2010; 16: 161–166.doi:
10.1016/j.ctcp.2010.01.003 PMID: 20621278
34. KassebaumNJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, et al. A systematic analysis of
global anemia burden from 1990 to 2010. Blood. 2014; 123: 615–624.doi: 10.1182/blood-2013-06-
508325 PMID: 24297872
35. Saunders AV, Craig WJ, Baines SK, Posen JS. Iron and vegetarian diets. MJA Open. 2012; Suppl 2:
11–16. Availabe: https://www.mja.com.au/open/2012/1/2/iron-and-vegetarian-diets.
36. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, random-
ized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in
Risk Factors and Birth Outcomes of Anaemia in Pregnancy - SCOPE Study
PLOS ONE | DOI:10.1371/journal.pone.0122729 April 15, 2015 14 / 15
Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999; 340: 409–417.
doi: 10.1056/NEJM199902113400601 PMID: 9971864
37. Hébert PC, Carson JL. Transfusion threshold of 7 g per deciliter—the new normal. N Engl J Med. 2014;
371: 1459–1461.doi: 10.1056/NEJMe1408976 PMID: 25270276
38. Kvalvik LG, Nilsen RM, Skjærven R, Vollset SE, Midttun O, Ueland PM, et al. Self-reported smoking
status and plasma cotinine concentrations among pregnant women in the Norwegian Mother and Child
Cohort Study. Pediatr Res. 2012; 72: 101–107.doi: 10.1038/pr.2012.36 PMID: 22441375
Risk Factors and Birth Outcomes of Anaemia in Pregnancy - SCOPE Study
PLOS ONE | DOI:10.1371/journal.pone.0122729 April 15, 2015 15 / 15
